D-B483

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameD-B483
Drug Alias NameD-B483
ClassificationDiagnostic agent (In vivo) > Radionuclide Imaging agent
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSolid tumoursGlioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAshvattha Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesAshvattha Therapeutics
Inactive CompaniesN/A
Active IndicationsSolid tumoursGlioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A